Clinical Trials Sponsored by Agenus, Inc.

Total 37386 results

Venus Concept

Completed

Clinical Evaluation of Fractional Radiofrequency for the Treatment of Acne Scarring

Acne Scars

United States
Medical College of Wisconsin
Agency for Healthcare Research and Quality (AHRQ); MetaStar, Inc.

Active, not recruiting

WI-INTUIT: Bridging Community Based Continence Promotion and Primary Care (WI-INTUIT)

Urinary Incontinence

United States
Child Advocacy International
United States Agency for International Development (USAID); John Snow, Inc.

Completed

Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training

Heart Failure | Sepsis | Asthma | Coma | Seizure

Pakistan
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
McGill University
World Anti-Doping Agency; International Olympic Committee; Phantom Compass; Digitalmill...

Unknown

Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes

Performance Enhancing Product Use | Doping in Sport
St Stephens Aids Trust
United States Agency for International Development (USAID); Mylan Inc.

Unknown

Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid

HIV

Uganda, United Kingdom
University of California, Los Angeles
Defense Advanced Research Projects Agency; Defense Group, Inc.

Completed

PTSD Affect Labeling Study

Post-traumatic Stress Disorder | Post-Traumatic Stress Disorder, Chronic

United States
British Columbia Cancer Agency

Not yet recruiting

PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer (PATH)

Head and Neck Cancer
British Columbia Cancer Agency

Recruiting

PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc (PREDiCTc)

Cancer

Canada
British Columbia Cancer Agency

Recruiting

[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer

Prostatic Cancer | Prostatic Neoplasm

Canada
British Columbia Cancer Agency

Recruiting

PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA (PROTRACT)

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Canada
British Columbia Cancer Agency

Recruiting

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

Canada
Environmental Protection Agency (EPA)

Enrolling by invitation

Modification of Ambient Air Pollution Exposure and Cardiopulmonary Outcomes by Socioeconomic Status and Nutrition (SENSE)

Air Pollution | Pollution; Exposure | Nutrition, Healthy

United States
British Columbia Cancer Agency

Withdrawn

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Neuroendocrine Tumors | Carcinoid Tumor | Gastrinoma | Insulinoma | Vipoma | Gastroenteropancreatic Neuroendocrine Tumor | Pulmonary Carcinoid Tumor

Canada
British Columbia Cancer Agency

Withdrawn

FDGal PET/CT to Detect Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver Disease

Canada
British Columbia Cancer Agency

No longer available

18F-FDOPA PET in Neuroendocrine Tumours

Thyroid Cancer, Medullary | Neuroblastoma | Pheochromocytoma | Carcinoid Tumor | Paraganglioma | Insulinoma

Canada
British Columbia Cancer Agency

Active, not recruiting

Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

Metastatic Tumors

Canada
Environmental Protection Agency (EPA)

Completed

Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults (RECAP)

Exposure to Pollution

United States
British Columbia Cancer Agency

Completed

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule (Dosepainting)

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath (Covid-VOC)

Covid19

Canada
British Columbia Cancer Agency

Completed

18F-AmBF3-TATE PET/CT for Imaging NET Patients

Neuroendocrine Tumors

Canada
Environmental Protection Agency (EPA)

Completed

Epigenetic Effect Modifications With Ozone Exposure on Healthy Volunteers (Geminoz)

Exposure to Environmental Pollution, Non-occupational

United States
British Columbia Cancer Agency

Completed

18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

Melanoma | Lymphoma | Lung Neoplasms | Colorectal Neoplasms | Brain Neoplasms

Canada
British Columbia Cancer Agency

Unknown

Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy

Arthralgia | Myalgia | Invasive Breast Cancer | Chemotherapeutic Toxicity
Environmental Protection Agency (EPA)

Completed

The Interaction of Social Factors With Air Pollution (SOZIAL)

Exposure to Environmental Pollution, Non-occupational

United States
British Columbia Cancer Agency

Unknown

Feasibility Study of MRI Imaging on Parotid Gland Stimulation (SPIT)

Parotid Neoplasms

Canada
British Columbia Cancer Agency

Withdrawn

Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Canada
Environmental Protection Agency (EPA)

Completed

Epigenetic Effects of Diesel Exhaust and Ozone Exposure (Lamarck)

Exposure to Pollution | Inhalation of Ozone

United States
British Columbia Cancer Agency

Unknown

Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Rectal Bleeding

Canada
British Columbia Cancer Agency

Unknown

Randomized Anastrozole Exercise Trial (RAE)

Musculoskeletal Symptoms

Canada
British Columbia Cancer Agency

Completed

Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) (Anterior EPI)

Breast Cancer

Canada
Environmental Protection Agency (EPA)

Completed

Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers

Healthy

United States
International Atomic Energy Agency

Completed

Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

Head and Neck Cancer
British Columbia Cancer Agency

Completed

Bone Health in Gynecologic Cancers-does FOSAVANCE Help? (FOSAVANCE)

Ovarian Cancer

Canada
British Columbia Cancer Agency

Completed

Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial

Advanced Colorectal Cancer

Canada
British Columbia Cancer Agency

Recruiting

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Prostate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer

Canada
Shafer Clinic Fifth Avenue

Recruiting

Shafer Width and Girth: The Use of Injectable Fillers for Penile Enhancement

Micropenis

United States
British Columbia Cancer Agency

Recruiting

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

Pathologic Processes | Neoplasms | Neoplasm Metastasis | Neoplastic Processes

Canada
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada
British Columbia Cancer Agency

Recruiting

Partial Prostate Salvage High Dose Rate Brachytherapy (SalvageHDR)

Recurrent Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer (TAPER)

Endometrial Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
British Columbia Cancer Agency

Approved for marketing

18F-FDG PET Imaging in Cardiac Sarcoidosis

Cardiac Sarcoidosis

Canada
British Columbia Cancer Agency

Active, not recruiting

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease

Canada
British Columbia Cancer Agency

Completed

Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases (Amadeus)

Brain Metastases

Canada
British Columbia Cancer Agency

Completed

US-CT Fusion for Post Implant Dosimetry

Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer

Head and Neck Cancer | Radiotherapy Induced Mucositis

Canada
British Columbia Cancer Agency

Terminated

Intraprostatic MAXimal Simultaneous Boost

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

C-arm Cone-beam CT in Prostate Brachytherapy (C-arm)

Prostate Cancer

Canada

Clinical Trials Sponsored by Agenus, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations